{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Renal+Diseases&page=11", "query": { "condition": "Chronic Renal Diseases", "page": 11 }, "page_size": 10 }, "pagination": { "page": 11, "page_size": 10, "total_count": 1881, "total_pages": 189, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Renal+Diseases&page=12&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Renal+Diseases&page=10&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-15T01:56:13.247Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05356403", "title": "CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Kidney Diseases", "Pruritus" ], "interventions": [ { "name": "Difelikefalin 1 mg Oral Tablet", "type": "DRUG" }, { "name": "Placebo Oral Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cara Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 105, "start_date": "2022-08-26", "completion_date": "2024-02-26", "has_results": false, "last_update_posted_date": "2024-05-07", "last_synced_at": "2026-10-15T01:56:13.247Z", "location_count": 9, "location_summary": "Northridge, California • Miami, Florida • Miami Lakes, Florida + 5 more", "locations": [ { "city": "Northridge", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Weston", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05356403" }, { "nct_id": "NCT02268682", "title": "Explore Transplant at Home: Improving Low-Income ESRD Patients' Transplant Knowledge", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "End Stage Renal Disease" ], "interventions": [ { "name": "Patient-Guided", "type": "OTHER" }, { "name": "Educator-Guided", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "The Methodist Hospital Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 558, "start_date": "2014-07", "completion_date": "2016-08", "has_results": false, "last_update_posted_date": "2023-12-28", "last_synced_at": "2026-10-15T01:56:13.247Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02268682" }, { "nct_id": "NCT03277547", "title": "Kidney Function in Sickle Cell Anemia", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sickle Cell Disease", "Kidney Failure, Chronic" ], "interventions": [], "intervention_types": [], "sponsor": "Kenneth Ataga MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 300, "start_date": "2017-11-17", "completion_date": "2025-12-01", "has_results": false, "last_update_posted_date": "2025-01-27", "last_synced_at": "2026-10-15T01:56:13.247Z", "location_count": 3, "location_summary": "Chapel Hill, North Carolina • Columbus, Ohio • Memphis, Tennessee", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03277547" }, { "nct_id": "NCT00118326", "title": "Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Kidney Cancer", "Leukemia", "Lymphoma", "Myelodysplastic Syndromes", "Neuroblastoma", "Sarcoma" ], "interventions": [ { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "allogeneic bone marrow transplantation", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "18 Years", "sex": "ALL", "summary": "Up to 18 Years" }, "enrollment_count": null, "start_date": "2003-08", "completion_date": "2007-05", "has_results": false, "last_update_posted_date": "2010-05-14", "last_synced_at": "2026-10-15T01:56:13.247Z", "location_count": 2, "location_summary": "Nashville, Tennessee • Seattle, Washington", "locations": [ { "city": "Nashville", "state": "Tennessee" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00118326" }, { "nct_id": "NCT00811889", "title": "Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Kidney Disease", "Type 2 Diabetes", "Diabetic Nephropathy" ], "interventions": [ { "name": "Placebo", "type": "OTHER" }, { "name": "Bardoxolone Methyl (RTA 402)", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 227, "start_date": "2009-04-30", "completion_date": "2010-12-31", "has_results": false, "last_update_posted_date": "2025-05-29", "last_synced_at": "2026-10-15T01:56:13.247Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Montgomery, Alabama • Chula Vista, California + 36 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Mission Viejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00811889" }, { "nct_id": "NCT01074125", "title": "A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hyperphosphatemia", "End-Stage Renal Disease" ], "interventions": [ { "name": "ferric citrate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Keryx Biopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 154, "start_date": "2010-05", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2014-12-04", "last_synced_at": "2026-10-15T01:56:13.247Z", "location_count": 15, "location_summary": "Westminster, Colorado • Pembroke Pines, Florida • Augusta, Georgia + 10 more", "locations": [ { "city": "Westminster", "state": "Colorado" }, { "city": "Pembroke Pines", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Springfield", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01074125" }, { "nct_id": "NCT05828823", "title": "Incremental Hemodialysis: The TwoPlus Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "End-Stage Kidney Disease" ], "interventions": [ { "name": "Hemodialysis twice weekly", "type": "DEVICE" }, { "name": "Hemodialysis thrice weekly", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 350, "start_date": "2024-02-26", "completion_date": "2031-01", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-10-15T01:56:13.247Z", "location_count": 10, "location_summary": "Jacksonville, Florida • Atlanta, Georgia • Baltimore, Maryland + 7 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Jackson", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT05828823" }, { "nct_id": "NCT06322641", "title": "A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Atherosclerotic Cardiovascular Disease (ASCVD)", "Chronic Kidney Disease (CKD)", "Systemic Inflammation" ], "interventions": [ { "name": "No treatment given", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2024-03-26", "completion_date": "2024-05-10", "has_results": false, "last_update_posted_date": "2024-07-26", "last_synced_at": "2026-10-15T01:56:13.247Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06322641" }, { "nct_id": "NCT04156854", "title": "Intravascular Volume Expansion to Neuroendocrine-Renal Function Profiles in Chronic Heart Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "Quantitated Blood Volume Analysis", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2020-01-30", "completion_date": "2022-12-19", "has_results": false, "last_update_posted_date": "2023-02-08", "last_synced_at": "2026-10-15T01:56:13.247Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04156854" }, { "nct_id": "NCT07624305", "title": "A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Renal Insufficiency, Chronic" ], "interventions": [ { "name": "Balcinrenone/dapagliflozin", "type": "DRUG" }, { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Placebo matching Dapagliflozin", "type": "DRUG" }, { "name": "Placebo matching balcinrenone/dapagliflozin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 2800, "start_date": "2026-09-01", "completion_date": "2030-07-01", "has_results": false, "last_update_posted_date": "2026-09-24", "last_synced_at": "2026-10-15T01:56:13.247Z", "location_count": 68, "location_summary": "Huntsville, Alabama • Surprise, Arizona • Tempe, Arizona + 63 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Surprise", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Concord", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07624305" } ] }